Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest

Anton Kuratnik1, Virginia E Senapati, Rajeev Verma

  • 1Department of Molecular and Cell Biology, 91 North Eagleville Road, University of Connecticut, Storrs, CT 06269, United States.

Biochemical Pharmacology
|February 7, 2012
PubMed

Insights

Histone deacetylase inhibitors sensitize colon cancer cells to inflammatory cytokines like TNF and TRAIL by inducing prophase arrest. This finding offers potential new strategies for colon cancer therapy and prevention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Cell Biology

Background:

  • Colon cancer cells thrive in inflammatory tumor environments.
  • Developing strategies to enhance cancer cell sensitivity to inflammatory cytokines is crucial for effective therapy.

Purpose of the Study:

  • To investigate how colon cancer cells survive within the tumor's inflammatory milieu.
  • To identify therapeutic agents that sensitize colon cancer cells to inflammatory cytokines, such as tumor necrosis factor (TNF) and TNF-related apoptosis-inducing ligand (TRAIL).

Main Methods:

  • Analysis of chemopreventive and therapeutic agents, focusing on histone deacetylase (HDAC) inhibitors.
  • In vivo studies using AOM-induced colon tumors.
  • Cell cycle analysis and time-lapse imaging.
  • siRNA analysis targeting Aurora kinases.

Main Results:

  • HDAC inhibitors, specifically SAHA (suberoylanilide hydroxamic acid), effectively sensitize colon cancer cells to TNF- and TRAIL-mediated apoptosis.
  • SAHA administration enhances apoptosis in AOM-induced colon tumors, which exhibit elevated TNF levels.
  • SAHA-induced prophase arrest closely correlates with TNF- or TRAIL-induced apoptosis.
  • The Aurora kinase inhibitor VX680 also sensitizes cells to TNF and TRAIL, with Aurora kinase A identified as the key mediator.

Conclusions:

  • Agents that induce prophase arrest may sensitize cancer cells to inflammatory cytokines like TNF.
  • Circumvention of early mitotic checkpoints may contribute to cancer cell survival in inflammatory tumor microenvironments.
  • These findings suggest novel therapeutic and preventive strategies for colon cancer by targeting inflammatory pathways and cell cycle regulation.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...